Anaptysbio (ANAB) Cash from Investing Activities Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | -25.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.73% |
| Dec 31, 2025 | 50.65% |
| Sep 30, 2025 | 73.07% |
| Jun 30, 2025 | 35.95% |
| Mar 31, 2025 | 26.98% |
| Dec 31, 2024 | 23.90% |
| Sep 30, 2024 | 75.53% |
| Jun 30, 2024 | -27.33% |
| Mar 31, 2024 | 6.55% |
| Dec 31, 2023 | 139.09% |
| Sep 30, 2023 | 86.38% |
| Jun 30, 2023 | -31.45% |
| Mar 31, 2023 | 99.52% |
| Dec 31, 2022 | 74.65% |
| Sep 30, 2022 | -36.47% |
| Jun 30, 2022 | -47.77% |
| Mar 31, 2022 | -225.23% |
| Dec 31, 2021 | 26.23% |
| Sep 30, 2021 | -23.92% |
| Jun 30, 2021 | 143.27% |
| Mar 31, 2021 | 197.89% |
| Dec 31, 2020 | 26.48% |
| Sep 30, 2020 | 126.11% |
| Jun 30, 2020 | 47.48% |
| Mar 31, 2020 | 33.83% |
| Dec 31, 2019 | 1,492.28% |
| Jun 30, 2019 | 1,505.19% |
| Mar 31, 2019 | 552.58% |